Dr. Richard Jove is committed to developing more effective and safer therapies for the treatment of cancer as well as other diseases impacted by aging and inflammation.
Dr. Jove’s predoctoral training at Columbia University and postdoctoral training at Rockefeller University, New York, prepared him well for his scientific and leadership roles. After nearly a decade on the faculty of the University of Michigan Medical School and NCI Comprehensive Cancer Center in Ann Arbor, Dr. Jove was recruited to help establish the Moffitt Cancer Center, Tampa FL. He served as Professor and Director of the Molecular Oncology Program for a decade and then as Associate Director for Basic Research of Moffitt’s NCI Comprehensive Cancer Center.
Since 2005, Dr. Jove first served as Chair of Molecular Medicine and then as Director of the Beckman Research Institute at City of Hope in Los Angeles, CA. As Deputy Director of the City of Hope Comprehensive Cancer Center at the same time until 2012, one of his primary roles was to integrate the cancer research activities of the Beckman Research Institute and the NCI Comprehensive Cancer Center. He had continuous uninterrupted NIH grant funding since establishing his first lab in 1988 and published over 220 research articles to date.
As of July 1, 2013, Dr. Jove has been serving as the Director of VGTI Florida. In his leadership capacity as Director, CEO, and President of VGTI Florida, his priority is fostering collaboration for development of original scientific discoveries into innovative therapies for diseases of aging. With the recent establishment of the Center for Diseases Aging, the research focus will be cancer, cardiovascular disease, neurodegernative disorders, among others.